Purified Proteins
| Anaphylatoxins | Depleted Sera | Antibodies | Cells & Reagents | How to Order | About Us | Contact Us | Home
Name: Factor P-Dpl
Catalog Number: A339
Sizes Available: 1.0 mL/vial
Concentration: >50 mg protein/mL (see Certificate of Analysis for actual conc.)
Form: Frozen liquid
Activity: >80% versus NHS standard after reconstitution with factor P
Purity: No factor P detectable by immunodiffusion
Buffer: 10 mM sodium phosphate, 145 mM NaCl, pH 7.3
Preservative: None, 0.22 µm filtered
Storage: -70oC or below. Minimize freeze/thaw cycles.
Source:
for HBsAg and for antibodies to HCV, HIV-1 and HIV-II).
Precautions: Use normal precautions for
handling human blood products.
Origin: Manufactured in the
General Description
Normal human serum was depleted of factor P (properdin) by immunoaffinity chromatography. The product is tested for the absence of factor P by double immunodiffusion. Factor P is a positive regulator of alternative pathway complement activation. As a result, Factor P-Dpl is still capable of activating the alternative pathway but activation is slower than with properdin present. For example, lysis of rabbit erythrocytes by Factor P-Dpl requires 20-25 min to reach 50% without properdin, but with P added back or in NHS lysis requires only 5-7 min under otherwise identical conditions. Factor P-Dpl is certified to possess a functional alternative pathway for complement activation which is fully functional if reconstituted with properdin. Full reconstitution requires addition of 10 µg factor P/mL serum (Law, S.K.A. and Reid, K.B.M. (1995)). The normal human serum concentration of factor P has been variously reported to be between 4 and 20 µg/mL (Morley, B.J. and Walport, M.J. (2000); Morgan, B.P. (2000); Dodds, A.W. and Sim, R.B. (1997)).
Physical
Characteristics & Structure
Factor P-Dpl is supplied as a clear, straw-colored liquid containing all proteins of normal human serum except complement factor P (properdin) and C1q.
Function
Factor P-Dpl serum is not completely functionally deficient in alternative pathway activity, but without factor P the feedback loop of the alternative pathway does not activate or amplify as rapidly as with properdin present. The depleted serum is reconstituted with 10 µg/mL factor P (CompTech #A139) and tested to verify that a fully functional alternative pathway is restored. It is tested for alternative pathway function using rabbit erythrocytes (CompTech #B300). The Certificate of Analysis provided with each lot gives a description of the assays and specific titers for the depleted and reconstituted sera compared to normal human serum. Because the only difference in alternative pathway activity between Factor P-Dpl, reconstituted P-Dpl and NHS is the time to activation, a graph of the time course of each of these assays is provided with the Certificate of Analysis.
Assays
Two assays are used to analyze Factor P-Dpl. The first determines the time required for 50% lysis of rabbit erythrocytes in 20% serum containing 5 mM MgEGTA (CompTech #B106). Three samples are compared: NHS, Factor P-Dpl and Factor P-Dpl reconstituted with 10 ug/mL purified factor P (CompTech #A139). From these assays one can determine the time at which there is the maximum difference between the P-depleted and the reconstituted serum. This time is the best time of incubation to use to titer properdin activity in unknown samples. The second assay measures the APH50 of reconstituted Factor P-Dpl and compares this to the APH50 of NHS. The later assays measure how effective the reconstituted serum is in a functional alternative pathway assay by measuring the amount of serum needed to lyse 50% of 1.25 x 107 rabbit erythrocytes (CompTech #B300)) when incubated in GVBo (CompTech #B103) containing a final concentration of 5 mM MgEGTA (CompTech #B106) in a total volume of 100 µL for 10 min at 37oC. Various MgEGTA concentrations, from 3 mM to 13 mM, have been reported to be effective in alternative pathway assays. See the Certificate of Analysis for lot specific titer values.
No classical pathway activity is measured due to the absence of C1q, but it should be active if C1q was added. Lectin pathway activity is not routinely tested or certified, but it would be expected to be active.
Applications
Factor P-Dpl can be used to assay the functional activity of factor P (properdin) and to examine the behavior of the alternative pathway amplification system with and without factor P.
Precautions/Toxicity/Hazards
The source is human serum, therefore precautions appropriate for handling any blood-derived product must be used even though the source was shown by certified tests to be negative for HBsAg and for antibodies to HCV, HIV-1 and HIV-II.
Hazard
Code: B WGK
MSDS is available upon request.
References
Dodds, A.W. and Sim, R.B. editors (1997) Complement. A Practical Approach
(ISBN 019963539)
Law, S.K.A. and Reid, K.B.M. (1995) Complement 2nd
Edition (ISBN 0199633568)
Morgan, B.P. ed. (2000) Complement Methods
and Protocols. (ISBN
0-89603-654-5) Humana Press, Inc.,
Morley, B.J. and Walport, M.J.
(2000) The Complement Facts Book (ISBN 0127333606)
Academic Press,
FOR
RESEARCH USE ONLY.
NOT FOR HUMAN OR DRUG
USE.
Complement
Technology, Inc.
Phone: 903-581-8284
FAX: 903-581-0491
Email: contactCTI@aol.com
Web: www.ComplementTech.com